![Ye Liu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ye Liu
Chief Executive Officer at
OCUMENSION THERAPEUTICS
Net worth: 27 M $ as of 2026-08-30
Profile
Ye Liu currently works at Ocumension Therapeutics, as Chief Executive Officer & Executive Director from 2018.
Mr. Liu also formerly worked at Santen Pharmaceutical (China) Co. Ltd., as Chairman & General Manager from 2014 to 2018, EyePoint Pharmaceuticals, Inc., as Director from 2021 to 2024, Eisai China, Inc., as General Manager from 2009 to 2014, and Sandoz (China) Pharmaceutical Co., Ltd., as Head-Sales from 2006 to 2009.
Mr. Liu received his graduate degree in 2003 from Dalhousie University and undergraduate degree in 1993 from Zhongshan Hospital Fudan University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-09-10 | 40,918,730 ( 4.89% ) | 27 M $ | 2026-08-30 |
Ye Liu active positions
| Companies | Position | Start |
|---|---|---|
| OCUMENSION THERAPEUTICS | Chief Executive Officer | 2018-07-31 |
Former positions of Ye Liu
| Companies | Position | End |
|---|---|---|
| EYEPOINT, INC. | Director/Board Member | 2024-06-19 |
Santen Pharmaceutical (China) Co. Ltd.
 Santen Pharmaceutical (China) Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales ophthalmic pharmaceuticals | Chief Executive Officer | 2018-06-30 |
Eisai China, Inc.
 Eisai China, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Chief Executive Officer | 2014-08-31 |
Sandoz (China) Pharmaceutical Co., Ltd.
 Sandoz (China) Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Engages in the production of generic pharmaceuticals | Sales & Marketing | 2009-01-31 |
Training of Ye Liu
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
78
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
EyePoint Pharmaceuticals, Inc.
 EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
Dalhousie University
 Dalhousie University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Santen Pharmaceutical (China) Co. Ltd.
Santen Pharmaceutical (China) Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales ophthalmic pharmaceuticals | Health Technology |
Eisai China, Inc.
Eisai China, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Zhongshan Hospital Fudan University
 Zhongshan Hospital Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sandoz (China) Pharmaceutical Co., Ltd.
Sandoz (China) Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Engages in the production of generic pharmaceuticals | Health Technology |
Ocumension Therapeutics
 Ocumension Therapeutics Miscellaneous Commercial ServicesCommercial Services Operates as an ophthalmic pharmaceutical platform company that develops drugs | Commercial Services |
- Stock Market
- Insiders
- Ye Liu
